AbbVie
ABBV
#32
Rank
$297.27 B
Marketcap
$167.89
Share price
0.89%
Change (1 day)
2.32%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): $3.68

According to AbbVie's latest financial reports the company's current EPS (TTM) is $3.68. In 2022 the company made an earnings per share (EPS) of $6.66 an increase over its 2021 EPS that were of $6.49.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.68-44.72%
2022$6.662.63%
2021$6.49125.21%
2020$2.88-45.69%
2019$5.3048.35%
2018$3.587.6%
2017$3.32-9.3%
2016$3.6615.48%
2015$3.17185.53%
2014$1.11-57.11%
2013$2.59-21.69%
2012$3.3155.73%
2011$2.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.86-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.43 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.15 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.46 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.39 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.97 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.98-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.50-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.96-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA